| Summary: | The global incidence of breast cancer has increased. However, there are many impediments to the development of safe and effective anticancer drugs. The aim of the present study was to evaluate the effect of aviculin isolated from <i>Lespedeza cuneata</i> (Dum. Cours.) G. Don. (Fabaceae) on MCF-7 human breast cancer cells and determine the underlying mechanism. Using the bioassay-guided isolation by water soluble tetrazolium salt (WST-1)-based Ez-Cytox assay, nine compounds (four lignan glycosides (<b>1</b>–<b>4</b>), three flavonoid glycosides (<b>5</b>–<b>7</b>), and two phenolic compounds (<b>8</b> and <b>9</b>)) were isolated from the ethyl acetate (EA) fraction of the <i>L. cuneata</i> methanolic extract. Of these, aviculin (<b>2</b>), a lignan glycoside, was the only compound that reduced metabolic activity on MCF-7 cells below 50% (IC<sub>50</sub>: 75.47 ± 2.23 μM). The underlying mechanism was analyzed using the annexin V Alexa Fluor 488 binding assay and Western blotting. Aviculin (<b>2</b>) was found to induce apoptotic cell death through the intrinsic apoptosis pathway, as indicated by the increased expression of initiator caspase-9, executioner caspase-7, and poly (ADP-ribose) polymerase (PARP). Aviculin (<b>2</b>)-induced apoptotic cell death was accompanied by an increase in the Bax/Bcl-2 ratio. These findings demonstrated that aviculin (<b>2</b>) could induce breast cancer cell apoptosis through the intrinsic apoptosis pathway, and it can therefore be considered an excellent candidate for herbal treatment of breast cancer.
|
|---|